Rapamycin treatment significantly suppressed radiation-induced senescence-associated β-galactosidase activity (p=0.0034) and reduced monocyte adhesion (p=0.0011) in human coronary artery endothelial cells.
Does rapamycin mitigate radiation-induced senescence and pro-atherogenic phenotypes in human coronary artery endothelial cells?
mTOR inhibition with rapamycin mitigates radiation-induced endothelial senescence and early atherogenic dysfunction in vitro, suggesting a potential therapeutic target for radiation-induced vascular injury.
p-value: p=0.0034
Abstract Ionising radiation (IR) is a recognised risk factor for cardiovascular disease (CVD), yet the mechanisms linking it to exposure remain incompletely understood. We show that IR drives a pro-atherogenic phenotype in human coronary artery endothelial cells (HCAECs) through the induction of cellular senescence, and that rapamycin attenuates these effects. IR triggered hallmark senescence features, including elevated senescence-associated-β-galactosidase activity, nuclear enlargement, and increased Cyclin dependent kinase inhibitor 1 A and p53 expression. Functionally, irradiated HCAECs displayed impaired barrier integrity and heightened monocyte adhesion. Transcriptomic and proteomic profiling revealed broad IR-induced alterations enriched in DNA damage response, cell-cycle arrest, senescence, proteostasis, and immune-related pathways. These findings establish a mechanistic link between radiation-induced endothelial senescence and early atherogenic-associated dysfunction, demonstrating that senescence is a driver of pro-atherogenic phenotypes in HCAECs in vitro. Importantly, mTOR inhibition is identified as a promising strategy to counteract radiation-associated endothelial dysfunction. This work positions senescence as a tractable therapeutic target in radiation-induced vascular injury.
Christopher Whiteman (Tue,) conducted a other in Radiation-induced atherosclerosis and endothelial dysfunction. Rapamycin vs. 10 Gy X-ray alone (no rapamycin) was evaluated on Senescence-associated β-galactosidase (SA-β-Gal) activity (p=0.0034). Rapamycin treatment significantly suppressed radiation-induced senescence-associated β-galactosidase activity (p=0.0034) and reduced monocyte adhesion (p=0.0011) in human coronary artery endothelial cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: